| Original language | English (US) |
|---|---|
| Pages (from-to) | 1031-1032 |
| Number of pages | 2 |
| Journal | JAMA - Journal of the American Medical Association |
| Volume | 320 |
| Issue number | 10 |
| DOIs | |
| State | Published - Sep 11 2018 |
| Externally published | Yes |
Bibliographical note
Funding Information:completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Khanna reports receipt of personal fees from Premier Inc, Merck and Co, Facile Therapeutics, and Pro Biotech LLC and a grant from Rebiotix Inc. No other disclosures were reported.